At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,164 enrolled
Drug / intervention
Wearable Cardioverter Defibrillatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-market Clinical Follow-up Study Evaluating the Efficacy and Safety of LifeVest in Real-life Settings in France
In Brief
An observational study evaluating Wearable Cardioverter Defibrillator for Sudden Cardiac Death and 3 related conditions. Completed, enrolled 1,164 participants across 2 sites.
Detailed Summary
This post-market study is a prospective observational study evaluating the efficacy and safety of the LifeVest in real-life settings.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartFeb 2017
First PostedOct 2017
Primary CompletionSep 2018
Study CompletionMar 2019
TodayJul 2026
First PostedOct 24, 2017
Enrollment StartFeb 2, 2017
Primary CompletionSep 30, 2018
Study CompletionMar 30, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.7 years ago
Interventions
Wearable Cardioverter Defibrillatordevice
A non-invasive wearable cardioverter defibrillator detects and treats VT/VF without the need for bystander intervention